Clinical characteristics, risk factors and outcomes of COVID-19 in SCI
Research type
Research Study
Full title
Clinical characteristics, risk factors and outcomes of COVID-19 in spinal cord injuries population: The Stoke Mandeville Experience
IRAS ID
286009
Contact name
Wail Ahmed
Contact email
Sponsor organisation
Buckinghamshire Healthcare NHS Trust
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 3 months, 1 days
Research summary
As the whole world has experienced, COVID-19 has affected all the sectors of the population including people with spinal cord injury (SCI). The SCI population is considered vulnerable due to the increased risk of respiratory failure (difficulty breathing) and injury-related immuno-suppression (reduction in the ability to fight infections) following tetraplegia (not able to feel or use arms and legs) and paraplegia (not able to feel or use legs). Also, it is not currently known how Covid-19 may affect people with SCI differently than the general population because of how a SCI affects normal functioning of the nervous system and other areas.
As very little is known around COVID-19 within the SCI population this study will evaluate the characteristics and risk factors of COVID-19 in SCI population and see if any patterns exist.
REC name
N/A
REC reference
N/A